The emerging Janus face of SVEP1 in development and disease

Trends Mol Med. 2023 Sep 4:S1471-4914(23)00187-9. doi: 10.1016/j.molmed.2023.08.002. Online ahead of print.ABSTRACTSushi, von Willebrand factor type A, EGF, and pentraxin domain containing 1 (SVEP1) is a large extracellular matrix protein that is also detected in circulation. Recent plasma proteomic and genomic studies have revealed a large number of associations between SVEP1 and human traits, particularly chronic disease. These include associations with cardiac death and disease, diabetes, platelet traits, glaucoma, dementia, and aging; many of these are causal. Animal models demonstrate that SVEP1 is critical in vascular development and disease, but its molecular and cellular mechanisms remain poorly defined. Future studies should aim to characterize these mechanisms and determine the diagnostic, prognostic, and therapeutic value of measuring or intervening on this enigmatic protein.PMID:37673700 | DOI:10.1016/j.molmed.2023.08.002
Source: Trends in Molecular Medicine - Category: Molecular Biology Authors: Source Type: research